Syntax Research, Inc. Merck & Co., Inc. Transaction History
Syntax Research, Inc.
- $145 Billion
- Q1 2025
A detailed history of Syntax Research, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 34,034 shares of MRK stock, worth $2.63 Million. This represents 2.11% of its overall portfolio holdings.
Number of Shares
34,034
Previous 33,315
2.16%
Holding current value
$2.63 Million
Previous $3.31 Billion
7.82%
% of portfolio
2.11%
Previous 2.38%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,892Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.3 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.3 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.6 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $195B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...